ArticleJournal of medicinal chemistry2021

Discovery of an Orally Bioavailable Small-Molecule Inhibitor for the β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction.

Zhen Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.